NOVONIX Ltd Files Form 6-K for April 2024

Ticker: NVNXF · Form: 6-K · Filed: Apr 3, 2024 · CIK: 1859795

Novonix LTD 6-K Filing Summary
FieldDetail
CompanyNovonix LTD (NVNXF)
Form Type6-K
Filed DateApr 3, 2024
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, foreign-private-issuer, reporting-update

TL;DR

NOVONIX filed a 6-K, confirming 20-F annual report filing and providing routine foreign private issuer updates.

AI Summary

NOVONIX Limited filed a Form 6-K on April 3, 2024, reporting information for the month of April 2024. The filing indicates that NOVONIX is a foreign private issuer and will file its annual reports under cover of Form 20-F. The document primarily serves as a report of foreign private issuer information.

Why It Matters

This filing provides routine updates for foreign private issuers like NOVONIX, informing investors about their reporting status and adherence to SEC regulations.

Risk Assessment

Risk Level: low — This is a routine administrative filing by a foreign private issuer and does not contain material new financial or operational information.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to provide information that the issuer makes or is required to make public in its home country or to security holders.

Which annual report form will NOVONIX Limited file?

NOVONIX Limited will file its annual reports under cover of Form 20-F.

What is the filing date of this Form 6-K?

This Form 6-K was filed on April 3, 2024.

Where is NOVONIX Limited's principal executive office located?

NOVONIX Limited's principal executive office is located at Level 38, 71 Eagle Street, Brisbane, QLD 4000, Australia.

Does this filing indicate NOVONIX is submitting the Form 6-K in paper format?

No, the filing indicates by check marks that NOVONIX is not submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1) or Rule 101(b)(7).

Filing Stats: 198 words · 1 min read · ~1 pages · Grade level 13 · Accepted 2024-04-03 08:08:55

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NOVONIX LIMITED By: /s/ Dr. John Christopher Burns Dr. John Christopher Burns Chief Executive Officer Date: April 3, 2024

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing